Bharat Biotech update the efficacy of Covaxin to 65.2% against the Delta variant – ET HealthWorld

Bharat Biotech update the efficacy of Covaxin to 65.2% against the Delta variant – ET HealthWorld

Commending the investigators from AIIMS on the BBV152 study published in Lancet Infectious Diseases, Bharat…

View More Bharat Biotech update the efficacy of Covaxin to 65.2% against the Delta variant – ET HealthWorld
Bharat Biotech’s COVAXIN® Phase III data published in The Lancet – ET HealthWorld

Bharat Biotech’s COVAXIN® Phase III data published in The Lancet – ET HealthWorld

Hyderabad, November 12, 2021: Bharat Biotech, a global leader in vaccine development and innovation, announced…

View More Bharat Biotech’s COVAXIN® Phase III data published in The Lancet – ET HealthWorld
Bharat Biotech’s partner seeks Covaxin nod in US for children between 2 and 18 years – ET HealthWorld

Bharat Biotech’s partner seeks Covaxin nod in US for children between 2 and 18 years – ET HealthWorld

Bharat Biotech’s partner in the United States for the Covid-19 vaccine-Ocugen on Friday sought emergency…

View More Bharat Biotech’s partner seeks Covaxin nod in US for children between 2 and 18 years – ET HealthWorld
WHO says likely to receive clarifications from Bharat Biotech on Covaxin by weekend – ET HealthWorld

WHO says likely to receive clarifications from Bharat Biotech on Covaxin by weekend – ET HealthWorld

The World Health Organisation on Wednesday said it expects to receive clarifications from Bharat Biotech…

View More WHO says likely to receive clarifications from Bharat Biotech on Covaxin by weekend – ET HealthWorld
WHO seeks ‘additional clarifications’ from Bharat Biotech for Covaxin to conduct final ‘risk-benefit assessment’ – ET HealthWorld

WHO seeks ‘additional clarifications’ from Bharat Biotech for Covaxin to conduct final ‘risk-benefit assessment’ – ET HealthWorld

The World Health Organisation’s technical advisory group on Tuesday sought “additional clarifications” from Bharat Biotech…

View More WHO seeks ‘additional clarifications’ from Bharat Biotech for Covaxin to conduct final ‘risk-benefit assessment’ – ET HealthWorld
PM launches Rs 64,000 cr Ayushman Bharat Health Infrastructure Mission in UP – ET HealthWorld

PM launches Rs 64,000 cr Ayushman Bharat Health Infrastructure Mission in UP – ET HealthWorld

Varanasi : Launching PM Ayushman Bharat Health Infrastructure Mission in Kashi (Uttar Pradesh) today, Prime…

View More PM launches Rs 64,000 cr Ayushman Bharat Health Infrastructure Mission in UP – ET HealthWorld
We are waiting for DCGI approval for children’s Covid-19 vaccine: Bharat Biotech Chairman – ET HealthWorld

We are waiting for DCGI approval for children’s Covid-19 vaccine: Bharat Biotech Chairman – ET HealthWorld

NEW DELHI: Chairman and Managing Director of Bharat Biotech, Dr. Krishna Ella on Saturday said…

View More We are waiting for DCGI approval for children’s Covid-19 vaccine: Bharat Biotech Chairman – ET HealthWorld
‘Cannot cut corners’ in approving Covaxin: WHO, seeks more info from Bharat Biotech – ET HealthWorld

‘Cannot cut corners’ in approving Covaxin: WHO, seeks more info from Bharat Biotech – ET HealthWorld

United Nations/Geneva: The World Health Organisation on Monday said it was expecting additional information from…

View More ‘Cannot cut corners’ in approving Covaxin: WHO, seeks more info from Bharat Biotech – ET HealthWorld
Covaxin Junior: Bharat Biotech’s kids’ vaccine is good news. But why is its vaccine for adults yet to get WHO clearance? – ET HealthWorld

Covaxin Junior: Bharat Biotech’s kids’ vaccine is good news. But why is its vaccine for adults yet to get WHO clearance? – ET HealthWorld

Bharat Biotech is on the threshold of becoming the second Indian vaccine maker to receive…

View More Covaxin Junior: Bharat Biotech’s kids’ vaccine is good news. But why is its vaccine for adults yet to get WHO clearance? – ET HealthWorld
IPL 2021, RCB vs DC: Bharat’s last-ball six against Delhi Capitals seals it for Royal Challengers Bangalore | Cricket News – Times of India

IPL 2021, RCB vs DC: Bharat’s last-ball six against Delhi Capitals seals it for Royal Challengers Bangalore | Cricket News – Times of India

Dasher combines with Maxwell to make light of targetIn the dress rehearsal before the playoffs,…

View More IPL 2021, RCB vs DC: Bharat’s last-ball six against Delhi Capitals seals it for Royal Challengers Bangalore | Cricket News – Times of India
Only 1 in 11 gets Covaxin as Bharat Biotech falls short of production targets – ET HealthWorld

Only 1 in 11 gets Covaxin as Bharat Biotech falls short of production targets – ET HealthWorld

MUMBAI: Homegrown Covaxin was to play a major role in vaccination against Covid-19. But eight…

View More Only 1 in 11 gets Covaxin as Bharat Biotech falls short of production targets – ET HealthWorld
IVI and Bharat Biotech jointly launch Global Chikungunya Vaccine phase-II/III trial in Costa Rica – ET HealthWorld

IVI and Bharat Biotech jointly launch Global Chikungunya Vaccine phase-II/III trial in Costa Rica – ET HealthWorld

The International Vaccine Institute (IVI) today announced that the first participant received Bharat Biotech’s chikungunya…

View More IVI and Bharat Biotech jointly launch Global Chikungunya Vaccine phase-II/III trial in Costa Rica – ET HealthWorld
Chandigarh leads in bringing hospitals under Ayushman Bharat ambit – ET HealthWorld

Chandigarh leads in bringing hospitals under Ayushman Bharat ambit – ET HealthWorld

CHANDIGARH: After Kerala and Punjab, Chandigarh is leading in private hospitals empanelled under Ayushman Bharat-Pradhan…

View More Chandigarh leads in bringing hospitals under Ayushman Bharat ambit – ET HealthWorld
Govt approves Bharat Biotech’s Ankleshwar plant to produce Covaxin: Mandaviya – ET HealthWorld

Govt approves Bharat Biotech’s Ankleshwar plant to produce Covaxin: Mandaviya – ET HealthWorld

Health Minister Mansukh L Mandaviya Union minister Mansukh Mandaviya on Tuesday said the government has…

View More Govt approves Bharat Biotech’s Ankleshwar plant to produce Covaxin: Mandaviya – ET HealthWorld
Bharat Biotech’s Covaxin effective against Delta Plus variant of COVID-19: Study – ET HealthWorld

Bharat Biotech’s Covaxin effective against Delta Plus variant of COVID-19: Study – ET HealthWorld

Bharat Biotech‘s COVID-19 vaccine Covaxin (BBV152) is effective against Delta Plus (AY.1) variant of the…

View More Bharat Biotech’s Covaxin effective against Delta Plus variant of COVID-19: Study – ET HealthWorld
Brazil’s health regulator scraps Bharat Biotech’s EUA application of Covaxin – ET HealthWorld

Brazil’s health regulator scraps Bharat Biotech’s EUA application of Covaxin – ET HealthWorld

REUTERS/Adnan Abidi/File Photo Brazil’s health regulator, ANVISA has scrapped Bharat Biotech’s application seeking emergency use…

View More Brazil’s health regulator scraps Bharat Biotech’s EUA application of Covaxin – ET HealthWorld